LATEST HEALTH NEWS
The direct oral anticoagulant(DOAC) Rivaroxaban is more effective in lowering risk of post-procedure venous thromboembolism (VTE) without increasing bleeding risk.
from Medindia Health News https://ift.tt/33ZHr5v
The direct oral anticoagulant(DOAC) Rivaroxaban is more effective in lowering risk of post-procedure venous thromboembolism (VTE) without increasing bleeding risk.
from Medindia Health News https://ift.tt/33ZHr5v
No comments
Thanks for comment via will connect you within 24 hours.